Role of clinical and biochemical inflammation in structural progression of patients with psoriatic arthritis

OBJECTIVE: To determine the contribution of clinical and biochemical inflammation to structural progression of patients with psoriatic arthritis (PsA). METHODS: We analysed patients from the Infliximab Multinational Psoriatic Arthritis Controlled Trial 2 trial (infliximab vs placebo). We obtained to...

Descripción completa

Detalles Bibliográficos
Autores principales: Borst, Carina, Alasti, Farideh, Smolen, Josef S, Aletaha, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655607/
https://www.ncbi.nlm.nih.gov/pubmed/34880129
http://dx.doi.org/10.1136/rmdopen-2021-002038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655607/
https://www.ncbi.nlm.nih.gov/pubmed/34880129
http://dx.doi.org/10.1136/rmdopen-2021-002038

Ejemplares similares